IG Pharmaceuticals: 2022 Outlook
Date: January 13, 2022
Presenter: Eric Axon & David Bussey
Eric and David discuss their Outlook for 2022. We’re shifting to Market Perform, several factors will limit outperformance, including bolt-on M&A, looming patent expirations, and an uptick in shareholder rewards.
Know More. Risk Better.®
Sign up to receive our latest credit insights direct to your inbox.